Investors / Switzerland / BiomedVC
BiomedVC
Venture capital · Switzerland · Europe
BiomedVC is a venture capital firm founded in 2021 as the successor to BioMedPartners, investing in early-stage life science companies. It supports founders in taking scientific innovation from academic labs into venture-backed biotechs developing therapeutics for unmet medical needs.
Invests inHealthcare & Biotech
In its own wordslife sciencesbiotechtherapeuticshealthcare
Your fit with BiomedVC
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsBiomedVC lists 8 checked portfolio companies on its own site and is named in 2 funding rounds, 2 of them as lead. Its most frequent entry is Seed, 50% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 43% of its companies are based in Germany. It invests most often alongside BioGeneration Ventures, Frazier Life Sciences and High-Tech Gründerfonds.
Counts come from funding rounds that name BiomedVC, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 50% |
| Series A | 50% |
| Series B | 0% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 1 | 1 |
| '26 | 1 | 1 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 15th | 8 companies |
| Recent activity | 69th | 2 rounds in 12 months |
| Early stage | 73th | 50% of entries at pre-seed or seed |
| Evidence | 95th | 25% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 58th | 3 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| BioGeneration Ventures | 2 |
| Frazier Life Sciences | 2 |
| High-Tech Gründerfonds | 2 |
| Jeito Capital | 2 |
| Asahi Kasei Ventures | 1 |
| Ascenta Capital | 1 |
| Avego | 1 |
| Bayern Kapital | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers8100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with BioGeneration Ventures
Compare BiomedVC head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with BiomedVC| Date | Company | Stage |
|---|---|---|
| 17 Mar 2026 | Seed Led | |
| 17 Dec 2025 | Series A Led |
Round details for BiomedVC
Amounts, full round histories and every co-investor in BiomedVC's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
8 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Alentis Therapeutics is a clinical-stage biotech company that treats cancer and reverses fibrosis by developing anti-Claudin-1 antibody-drug conjugates and monoclonal antibodies | Healthcare & Biotech | Portfolio page | ||
| Aleva Neurotherapeutics has developed a high resolution neurostimulation platform that delivers therapy with high selectivity. | Healthcare & Biotech | Portfolio page | ||
| Azafaros develops treatments for rare neurological diseases, including lysosomal storage disorders. | Healthcare & Biotech | Portfolio page | ||
| iDEL Therapeutics is advancing a new class of cancer medicines by delivering therapeutic payloads directly into the cytosol of tumor cells through a unique, pan-cancer uptake mechanism. | Healthcare & Biotech | Mar 2026Seed | Page + round | |
| Scenic Biotech is a neurometabolic company developing disease-modifying therapies that restore lysosomal function, a core driver of neurodegeneration. | Healthcare & Biotech | Portfolio page | ||
| T-CURX is a biotechnology company that develops autologous CAR-T cell therapies for cancer treatment | Healthcare & Biotech | Dec 2025Series A | Page + round | |
| TOLREMO therapeutics develops treatments to stop non-genetic cancer drug resistance | Healthcare & Biotech | Portfolio page | ||
| Tubulis generates uniquely matched antibody-drug conjugates for cancer treatment | Healthcare & Biotech | Portfolio page |
About this data
site last read 8 Nov 2026- Site
- biomedvc.com
- Last read
- 8 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 17 Dec 2025
- Companies checked
- 8
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get BiomedVC's profile as data
Pull BiomedVC's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/biomedvc.com
# also
GET /v1/firms/biomedvc.com/portfolio
GET /v1/firms/biomedvc.com/coinvestors
GET /v1/firms/biomedvc.com/news